Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06929494
Starting soon Observational

Candidemia in Critically Ill Patients

NCT06929494 · tracked via the Priya Life Science Israel tracker
Phase
Observational
Started
2025-08-01
Last updated
2025-04-16

Condition(s) studied

Sepsis

Investigational drug(s) / intervention(s)

Identification of risk factors for candidemia

Identification of risk factors for candidemia: Identification of risk factors for candidemia

Study summary

Candidal sepsis (candidemia) is a criticals problem in patients hospitalized in the intensive care unit, with a significant impact on morbidity and mortality. Risk factors for candidemia in intensive care patients included age, presence of a central venous catheter, inpatient surgery, and administration of parenteral nutrition (TPN). Mortality in patients with candidemia is estimated at 50-60%. Early identification and treatment, including control of the source of infection, are essential to improve morbidity and mortality in these patients.

In this study, we would like to identify risk factors for the development of candidemia in intensive care patients, including those who have not undergone abdominal surgery, and to examine what percentage of patients who developed candidemia were given empirical antifungal therapy and what factors influenced the decision to give or not to give such empirical therapy.

Study design: A retrospective study based on data collection from computerized systems will include patients who were hospitalized in the intensive care unit from January 2014 to December 2024 and were diagnosed with Candida in at least one blood culture.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: Patients admitted to the ICU from January 2014 to December 2024 and had at least one positive blood culture for candidemia - Exclusion Criteria: Missing data \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Meir Medical Center Kfar Saba Israel

More Meir Medical Center trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06929494 on ClinicalTrials.gov ↗ ← All trials in Israel